A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
Oncogene 2015 Jan .
Wang N, Ding H, Liu C, Li X, Wei L, Yu J, Liu M, Ying M, Gao W, Jiang H, Wang
The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis.
British journal of cancer 2004 Feb 90 (4): 888-91.
Koppert L B, Schutte M, Abbou M, Tilanus H W, Dinjens W N